Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on Oct 04, 2023 7:32pm
215 Views
Post# 35670057

RE:RE:RE:RE:RE:RE:RE:For those of you

RE:RE:RE:RE:RE:RE:RE:For those of you
FGPstock wrote:

 

wild1, if big pharma knew the potential of this technology, why would have someone bought into the company. This is something I struggle w. Seems like the only ones who believe in the technology are us retail investors. Research capital only has an .80 target and they have to like is because they raise 95% of the funds for Tlt.  Most of us feel this technology should get 10,20,50+ dollars. We have a hard time raising money when the potential could b more than any other investment. I have been thinkin this for 7+ years, so maybe I am blind, but 20 cents doesn't make sense

FGPstock you have been here for 7 years and you don't even know  why at this point in time big pharma show no interest in TLT treatment.

Big Pharma do not invest time and money in treatments that have not been approved by the FDA.

It has been said many time before on this board, Big Pharma are not gamblers.(the fact that you said you are blind, could explain why you do not understand this).

Strange post for somebody that has been here for 7 years.
<< Previous
Bullboard Posts
Next >>